Defective survival of haematopoietic precursors |
AK2 |
Regulates the adenine nucleotide composition and catalyses the reversible transfer of phosphate groups |
T–B–NK– |
1p35.1 |
AR |
Lymphopenia, hypoplasia of secondary lymphoid organs and thymus, multiple infections, profound neutropenia, hearing abnormality, thymic dystrophy |
Toxic metabolite accumulation |
ADA |
Component of the purine salvage pathway. Removes toxic metabolites and prevents inhibition of lymphoid cells |
T–B–NK– |
20q13.11 |
AR |
Multiple recurrent opportunistic infections, hypoplasia, FTT, skeletal alterations |
PNP |
Reversibly catalyses the phosphorolysis of purine nucleosides |
T–B + NK– |
14q11.2 |
AR |
Persistent opportunistic infections, autoimmune disorders |
Cytokine signalling anomalies |
IL2RG |
Required for the activation of JAK3 for intracellular signal transduction |
T–B + NK– |
Xq13.1 |
XL |
Recurrent multiple opportunistic infections (Pneumocystis jirovecii), failure to thrive, oral candidiasis, absent tonsils and lymph nodes |
JAK3 |
Tyrosine Kinase., essential to differentiate haematopoietic cells |
T–B + NK– |
19p13.1 |
AR |
Protracted diarrhoea, failure to thrive, life-threatening opportunistic infections |
IL7RA |
Essential development of T-cell and activation of JAK3 kinase |
T–B + NK+ |
5p13 IL7 |
AR |
Diarrhoea, persistent rotavirus gastroenteritis, weight loss, progressive cough, vomiting, poor appetite, failure to thrive |
V(D)J recombination and problems in T-cell receptor |
RAG1 or RAG2 |
Recombinases required for DNA recombination in B and T cell development |
T–B–NK+ |
11p13 |
AR |
Apart from opportunistic infections, patients can also develop fetures of Omenn syndrome (hepatosplenomegaly, lymph node swelling, eczema, eosinophilia, elevated IgE) and granuloma formation |
Artemis |
DNA repair process during V(D)J recombination |
T–B–NK+ |
10p |
AR |
|
DNA PKcs |
Repair of double-stranded DNA breaks and in the process of recombination |
T–B–NK+ |
8q11.21 |
AR |
Recurrent oral candidiasis, lower respiratory tract infections, failure to thrive, growth failure, microcephaly, and seizures |
NHEJI |
DNA repair factor involved in the NHEJ pathway |
T–B–NK+ |
2q35 |
AR |
Neural disorders, recurrent bacterial infections, microcephaly, growth retardation, bird-like face, increased radiosensitivity |
LIG4 |
Mediates V(D)J recombination and DSB repair through the NHEJ pathway |
T–B–NK+ |
13q33.3 |
AR |
Microcephaly, facial dysmorphisms, retarded growth, neurological abnormalities, bone marrow failure, pancytopenia |
TCR abnormalities |
CD45 |
Protein tyrosine phosphatase essential for signal transduction |
T–B + NK+ |
1q31-q32 |
AR |
Failure to thrive, diarrhoea, oral thrush, pneumonia, disseminated BCG infection |
CD3δ |
TCR/CD3 complex component, involved in signal transduction |
T–B + NK+ |
11q23.3 |
AR |
Defective T-cell development and signal transduction |
CD3ε |
Part of TCR-CD3 complex, involved in T-cell development |
T–B + NK+ |
11q23.3 |
AR |
Defective T-cell development, immunodeficiency |
CD3ζ |
Component of TCR-CD3 complex, important for antigen recognition to different signal-transduction pathways intracellularly |
T–B + NK+ |
1q24.2 |
AR |
Erythroderma, protracted diarrhoea, pulmonary abscess, impaired immune response. |
CORO 1A |
Cell cycle progression, signal transduction, gene regulation and cell death |
T–B–NK+ |
16p11.2 |
AR |
T cell lymphopenia, susceptibility to infection and immune dysregulation |
Thymic abnormalities |
FOXNI |
Required for thymic epithelial cell development, proliferation and terminal differentiation of TEC sublineages, T cell progenitor growth, and fate determination |
T–/lowB + NK+ |
17q11.2 |
AR |
Hairlessness and athymia, Atrophic thymus, T-cell immunodeficiency, congenital alopecia, nail dystrophy |
DiGeorge syndrome |
Disorder due to microdeletion of chromosome 22 |
T–B + NK+ |
22q11.2 |
AD/Denovo |
Psychiatric disorders, cardiac defects, immunodeficiency, facial malformations, hypocalcaemia, polydactyly |